Sony Biotechnology Inc.’s Post

Join us for this exciting webinar (May 22nd, 11 am ET) with Sony Biotechnology Inc.. Hear from Dr. David Hsu (Duke University) and Ryan Mote, PhD on how Single cell profiling is advancing precision therapeutics. Register here: https://lnkd.in/dGp-Su3w Event highlights: -Develop personalized treatments for gastrointestinal (GI) cancer patients. -Development of new miniature MicroOrganoSphere™ (MOS™) 3-D tissue model from patient tumors -Learn about Dr. Hsu’s promising technology being utilized in clinical trial for colorectal cancer at Duke University. #singlecell #flowcytometry #precisionmedicine #cancer #organoids

Join cardio-oncology experts, Dr Walter Schiffer, Dr Jose Alvarez-Cardona, Prof Dan Lenihan and Prof Joe Carver on 7 March to explore SGLT2 Inhibitor use on patients with cancer therapy-related cardiac dysfunction. Register here ➡️ https://ow.ly/ZEc250QLC0q 🔎Assess whether the use of SGLT2 inhibitors affects the occurrence of clinical events in this population 📚Explore the potential therapeutic interventions to mitigate cardiac dysfunction in cancer patients undergoing treatment #CardioOnc #Cardiology

📜We share the #Review "Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric Cancer" 👏by Niklas Gremke et al. Access the full paper here👉 https://lnkd.in/dze9rmrg Keywords: microsatellite instability; colorectal cancer; immune checkpoints

Statistics from American Cancer Society show that cancer is the second most common cause of death in the U.S. The most common cancer types are lung (1 in 16/17), colorectal (1 in 23/26), breast (1 in 8), and prostate (1 in 8). We’re helping cancer care providers gain the upper hand with MR applications that can be used to improve detection, clinical and operational efficiency, and outcomes. Check out our MR oncological applications 👉 bit.ly/3ChaTWV #GEHealthCare #medicalimaging #signamr #cancer

Statistics from American Cancer Society show that cancer is the second most common cause of death in the U.S. The most common cancer types are lung (1 in 16/17), colorectal (1 in 23/26), breast (1 in 8), and prostate (1 in 8). We’re helping cancer care providers gain the upper hand with MR applications that can be used to improve detection, clinical and operational efficiency, and outcomes. Check out our MR oncological applications 👉 bit.ly/3ChaTWV #GEHealthCare #medicalimaging #signamr #cancer

Did you know this ?? Would you want to know if you or your children were faced with a cancer diagnosis ?? Click below to find out more so you can talk to your clients about how to #Accelerate their healthcare options

Did you know that over 1/4 million each month in England alone, go through a cancer diagnosis and that c.50% are stage 3, 4 or advanced.... If so, you then realise why our Precision Cancer Medicine service may add significant extra value for your customers and may even save their life! Find out more below or register for our joint CPD webinar with our trusted partner Further Group on Weds 25th September - register here: https://lnkd.in/gpv9HMuv #PrecisionCancerMedicine #ZurichAccelerate #FarmorethanjustGlobalTreatment

Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases https://lnkd.in/d5nyNEFK

Introducing the 3rd Episode of ProNews' 4th Edition: "Proton therapy in Hepatocellular CA" In this episode, we dive into the most advanced treatment of hepatocellular carcinoma (liver cancer). Liver cancer, often associated with chronic liver disease, can benefit significantly from advanced proton therapy. Click here to watch video: https://lnkd.in/dsyn74tA Dr Ashu Abhishek Arjunan Manikandan #APCC #ProNews #ProtonTherapy #LiverCancer

Milestone in Cancer Treatment: First-Ever TIL Therapy for Solid Tumors Hits Clinics In the ever-evolving landscape of #cancer treatment, #researchers and #biotechnologists continually explore groundbreaking #therapies to combat solid tumors. One such promising approach is TIL therapy, which stands for Tumor-Infiltrating Lymphocyte therapy. This innovative method harnesses the body's immune system to target and eliminate cancer cells, offering a beacon of hope for patients facing solid tumors. Learn more: https://rb.gy/49y3ia #biotechnology #innovation #healthcare